Home/Filings/4/0001209191-22-033582
4//SEC Filing

Delaney William E IV 4

Accession 0001209191-22-033582

CIK 0001426800other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:00 PM ET

Size

5.8 KB

Accession

0001209191-22-033582

Insider Transaction Report

Form 4
Period: 2022-05-31
Delaney William E IV
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2022-05-31$1.92/sh4,164$8,00576,419 total
Footnotes (3)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.88 to $1.95, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
  • [F3]Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on May 13, 2022.

Issuer

ASSEMBLY BIOSCIENCES, INC.

CIK 0001426800

Entity typeother

Related Parties

1
  • filerCIK 0001812734

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:00 PM ET
Size
5.8 KB